James Engelhart
Director/Board Member chez Our Lady of Mercy Academy
Profil
M. James Engelhart, CPA, est directeur financier et trésorier de Biohaven Pharmaceutical Holding Co. Ltd. Il est membre du conseil d'administration de l'Académie Our Lady of Mercy. M. Engelhart a été précédemment employé en tant que directeur exécutif des finances chez Alexion Pharmaceuticals, Inc. et directeur financier chez Energizer SpinCo, Inc. et en tant qu'auditeur chez Coopers & Lybrand LLP. Il a obtenu un diplôme de premier cycle de l'université de Villanova et un diplôme de premier cycle de la Villanova School of Business.
Postes actifs de James Engelhart
| Sociétés | Poste | Début |
|---|---|---|
| Our Lady of Mercy Academy | Director/Board Member | - |
Anciens postes connus de James Engelhart
| Sociétés | Poste | Fin |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Director of Finance/CFO | 15/12/2021 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/05/2016 |
| ENERGIZER HOLDINGS, INC. | Corporate Officer/Principal | 01/07/2014 |
| Coopers & Lybrand LLP | Corporate Officer/Principal | 01/01/1991 |
Formation de James Engelhart
| Villanova School of Business | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ENERGIZER HOLDINGS, INC. | Consumer Non-Durables |
| Entreprise privées | 4 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
| Coopers & Lybrand LLP | Commercial Services |
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
| Our Lady of Mercy Academy |
